Menarini Biotech, a boutique, pure-play CDMO where we specialise in antibody discovery, development, and manufacture. We offer competitive pricing, fast clinical batch execution, regulatory expertise to accelerate biologics incl. enzymes, monoclonal antibodies, bi-specifics, fusion proteins, and ADCs from Research to FIH. From DNA to TOX in less then 6 months, GMP in 9 months. Those CMC services include manufacturability and scalability to ensure a seamless transition to GMP.
May 5, 17:00 - 17:15, room Osaka/Samarkand
Name | Position | Institution |
---|---|---|
Nicola Torre | GM | Menarini Biotech |